Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H9NO3.ClH |
Molecular Weight | 167.591 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NCC(=O)CCC(O)=O
InChI
InChIKey=ZLHFONARZHCSET-UHFFFAOYSA-N
InChI=1S/C5H9NO3.ClH/c6-3-4(7)1-2-5(8)9;/h1-3,6H2,(H,8,9);1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C5H9NO3 |
Molecular Weight | 131.1299 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:26 UTC 2023
by
admin
on
Fri Dec 15 15:01:26 UTC 2023
|
Record UNII |
V35KBM8JGR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
761520
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
||
|
NCI_THESAURUS |
C1420
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
GLIOLAN (AUTHORIZED: GLIOMA)
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
236807
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
885522
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/02/121
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
132969
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
SUB21578
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
DBSALT000934
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
CHEMBL601
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
V35KBM8JGR
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
5451-09-2
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
100000089584
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
II-53
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
18509
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
C1849
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
ALABEL
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | MARCH 2013 | ||
|
261715
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | RxNorm | ||
|
123608
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
m1713
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID5045914
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
226-679-5
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
V35KBM8JGR
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
1025715
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | |||
|
ALAGLIO
Created by
admin on Fri Dec 15 15:01:26 UTC 2023 , Edited by admin on Fri Dec 15 15:01:26 UTC 2023
|
PRIMARY | MARCH 2013 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|